What is considered a normal ejection fraction (EF) in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Ejection Fraction in Pregnancy

A normal ejection fraction during pregnancy ranges from 50% to 70%, which is identical to the reference range for non-pregnant women. 1

Standard Reference Values

  • The normal EF range of 50-70% applies throughout all trimesters of pregnancy, as pregnancy does not fundamentally alter what constitutes a normal ejection fraction measurement 1

  • The European Society of Cardiology establishes the normal range using the biplane method of discs at 53-73% (mean 63 ± 5%), which remains the standard regardless of pregnancy status 2

Physiological Context During Pregnancy

While the normal EF range remains unchanged, it's important to understand the hemodynamic adaptations that occur:

  • Cardiac output increases by 30-50% during pregnancy through increased stroke volume and elevated heart rate (15-20 bpm above baseline), but this occurs while maintaining normal ejection fraction 1

  • Systemic vascular resistance decreases due to endogenous vasodilators, reaching its lowest point in the second trimester 1

  • Heart rate typically increases to 80-95 beats per minute during early second trimester 1

Clinical Significance of Reduced EF in Pregnancy

An ejection fraction below 40% is considered reduced and represents a significant predictor of maternal cardiovascular events during pregnancy. 3, 1

High-Risk Thresholds

  • Women with EF <40% should be counseled against pregnancy due to substantially increased risk of complications 3, 1

  • EF <30% represents very high risk, with significantly worse fetal and neonatal outcomes, and these patients require intensive counseling about poor obstetrical outcomes 4, 5

  • EF <20% is considered a contraindication to pregnancy unless improved under treatment 4

Risk Stratification

The modified WHO risk classification uses EF thresholds for pregnancy risk assessment:

  • EF ≥50%: Standard prenatal cardiac monitoring is generally sufficient 1

  • EF 40-49% (borderline/mildly reduced): Requires more frequent monitoring during pregnancy 1

  • EF <40%: High-risk category requiring frequent echocardiographic surveillance every 4-8 weeks to assess for deterioration 3, 1

Monitoring Recommendations by EF Category

For women with normal EF (50-70%):

  • Standard prenatal cardiac monitoring is appropriate 1
  • No specific cardiac intervention or activity restriction is warranted based on EF alone 2

For women with mildly reduced EF (40-49%):

  • More frequent cardiac monitoring throughout pregnancy 1
  • Serial echocardiographic assessments to detect deterioration 1

For women with reduced EF (<40%):

  • Frequent echocardiographic surveillance every 4-8 weeks 3, 1
  • Joint cardiac and obstetric care in a specialist unit 3
  • Consideration of therapeutic anticoagulation due to increased thromboembolic risk 3

Important Caveats and Pitfalls

Measurement variability is a critical consideration:

  • EF measurements can vary between imaging modalities (echocardiography, MRI, nuclear imaging) and between interpreters 1, 2
  • When reporting EF as a numerical value, always specify the imaging modality and method of analysis 1
  • A single EF measurement may not be adequate, particularly for borderline values (41-49%) 2

Load dependency affects interpretation:

  • EF is load-dependent and cannot distinguish between preload, afterload, and intrinsic contractility 2
  • Volume status (hypovolemia/dehydration) can artificially elevate EF 2
  • Small ventricular cavity may produce artificially high EF calculations (>70%) 2

Subclinical dysfunction may be present despite normal EF:

  • Women who later develop peripartum cardiomyopathy (PPCM) have been shown to have normal EF during pregnancy (60% ± 6.6%) but abnormal systolic strain on advanced imaging 6
  • Consider global longitudinal strain (GLS) assessment if clinical suspicion of dysfunction exists despite preserved EF, with normal values being more negative than -16% 2

Peripartum Cardiomyopathy Considerations

PPCM typically presents with severely reduced EF in the peripartum period:

  • Most PPCM patients present peri- or post-partum with acute deterioration 3
  • Anticoagulation should be considered in PPCM patients with very low EF due to frequent peripheral and cerebral embolism 3
  • When EF has not normalized after PPCM, subsequent pregnancy should be strongly discouraged due to 30-50% recurrence risk 3

References

Guideline

Ejection Fraction Guidelines During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Measuring Ejection Fraction Using Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.